Info

Histologic Transformation of follicular lymphoma

  • ~3%/y risk of transformation from FL to DLBCL,

  • rapid nodal enlargement & rising LDH, ± systemic symptoms

  • Bx is required to diagnose transformation.

  • PET may be useful in determining a site for bx.

  • SUV values >10–13 suggest transformation (Ann Oncol 2009;20:508)

  • Transformation to DLBCL in a previously untreated pt treated similar to de novo DLBCL

  • If histologic transformation occurs after prior chemotherapy, consider consolidation w/ high dose therapy and autologous stem cell rescue in chemosensitive disease